These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32468331)

  • 21. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
    Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment.
    Tallet AV; Azria D; Barlesi F; Spano JP; Carpentier AF; Gonçalves A; Metellus P
    Radiat Oncol; 2012 May; 7():77. PubMed ID: 22640600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of cognitive function after brain irradiation.
    Surendran HP; Narmadha MP; Kalavagunta S; Sasidharan A; Dutta D
    J Oncol Pharm Pract; 2022 Jul; 28(5):1182-1188. PubMed ID: 35112915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States.
    Chin AL; Li G; Gephart MH; Sandhu N; Nagpal S; Soltys SG; Pollom EL
    World Neurosurg; 2020 Dec; 144():e797-e806. PubMed ID: 32971279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
    Trifiletti DM; Ballman KV; Brown PD; Anderson SK; Carrero XW; Cerhan JH; Whitton AC; Greenspoon J; Parney IF; Laack NN; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):255-260. PubMed ID: 31654784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
    Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
    J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
    Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
    J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous.
    Nieder C; Guckenberger M; Gaspar LE; Rusthoven CG; De Ruysscher D; Sahgal A; Nguyen T; Grosu AL; Mehta MP
    Radiat Oncol; 2019 Feb; 14(1):33. PubMed ID: 30770745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
    Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
    Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognition and radiation therapy for brain metastases: a new paradigm to define].
    Tallet A; Dhermain F; Taillia H; Ricard D; Mornex F; Métellus P
    Bull Cancer; 2013 Jan; 100(1):69-74. PubMed ID: 23302115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer.
    Tanguturi S; Warren LEG
    Curr Oncol Rep; 2019 Apr; 21(6):50. PubMed ID: 30993546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
    Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.